Gruenwald, B. Et Al. 2016. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. GASTROENTEROLOGY , vol.151, no.5 , 1011-1031.

Gruenwald, B., Harant, V., Schaten, S., Fruehschuetz, M., Spallek, R., Hoechst, B., ... Stutzer, K.(2016). Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver. GASTROENTEROLOGY , vol.151, no.5, 1011-1031.

Gruenwald, Barbara Et Al. "Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver," GASTROENTEROLOGY , vol.151, no.5, 1011-1031, 2016

Gruenwald, Barbara Et Al. "Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver." GASTROENTEROLOGY , vol.151, no.5, pp.1011-1031, 2016

Gruenwald, B. Et Al. (2016) . "Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver." GASTROENTEROLOGY , vol.151, no.5, pp.1011-1031.

@article{article, author={Barbara Gruenwald Et Al. }, title={Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver}, journal={GASTROENTEROLOGY}, year=2016, pages={1011-1031} }